Risk of type 2 diabetes among HIV-infected and healthy subjects in Italy

European Journal of Epidemiology

Volumn 27, Issue 8, 2012, Pages 657-665

  Galli, Laura ^a   Salpietro, Stefania ^a   Pellicciotta, Gabriele ^b   Galliani, Alberto ^b   Piatti, Piermarco ^a   Hasson, Hamid ^a   Guffanti, Monica ^a   Gianotti, Nicola ^a   Bigoloni, Alba ^a   Lazzarin, Adriano ^a,c   Castagna, Antonella ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b H San Raffaele Resnati Spa   (Italy)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Healthy HIV negative controls; HIV; Prevalence of type 2 diabetes; Risk factors

Indexed keywords

ANTIDIABETIC AGENT; CHOLESTEROL; GLUCOSE; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; BODY MASS; CD4 LYMPHOCYTE COUNT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETOGENESIS; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; ITALY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK ASSESSMENT; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ANTI-HIV AGENTS; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE TOLERANCE TEST; HIV INFECTIONS; HUMANS; ITALY; LIPIDS; MALE; MIDDLE AGED; OBESITY; ODDS RATIO; PREVALENCE; RISK FACTORS; SEX DISTRIBUTION;

EID: 84866520132     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-012-9707-5     Document Type: Article

References (27)

1. Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab. 2007;92:2506-12.
2. Brown TT, Cole SR, Li X, et al. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med. 2005;165:1179-84.
3. Kourtis AP, Bansil P, Kahn HS, Posner SF, Jamieson DJ. Diabetes trends in hospitalized HIV-infected persons in the United States, 1994-2004. Curr HIV Res. 2009;7:481-6.
4. Friis-Moller N, Sabin CA, Weber R, et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med. 2003;349:1993-2003.
5. Worm SW, De Wit S, Weber R, et al. Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the data collection on adverse events of anti- HIV drugs (D:A:D study). Circulation. 2009;119:805-11.
6. Tebas P. Insulin resistance and diabetes mellitus associated with antiretroviral use in HIV-infected patients: pathogenesis, prevention, and treatment options. J Acquir Immune Defic Syndr. 2008;49(Suppl 2):S86-92.
7. Deshpande AD, Harris-Hayes M, Schootman M. Epidemiology of diabetes and diabetes-related complications. Phys Ther. 2008;88:1254-64.
8. Brown TT, Tassiopoulos K, Bosch RJ, Shikuma C, McComsey GA. Association between systemic inflammation and incident diabetes in HIV-infected patients after initiation of antiretroviral therapy. Diabetes Care. 2010;33:2244-9.
9. Grinspoon S. Diabetes mellitus, cardiovascular risk, and HIV disease. Circulation. 2009;119:770-2.
10. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. Am Heart J. 1991;121:293-8.
11. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2009;32 Suppl 1:S62-S67.
12. De Wit S, Sabin CA, Weber R, et al. Incidence and risk factors for new-onset diabetes in HIV-infected patients: the data collection on adverse events of anti-HIV drugs (D:A:D) study. Diabetes Care. 2008;31:1224-9.
13. Brar I, Shuter J, Thomas A, Daniels E, Absalon J. A comparison of factors associated with prevalent diabetes mellitus among HIV-infected antiretroviral-naive individuals versus individuals in the National Health and Nutritional Examination Survey cohort. J Acquir Immune Defic Syndr. 2007;45:66-71.
14. Goulet JL, Fultz SL, Rimland D, et al. Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity? Clin Infect Dis. 2007;45:1593-601.
15. Butt AA, McGinnis K, Rodriguez-Barradas MC, et al. HIV infection and the risk of diabetes mellitus. AIDS. 2009;23: 1227-34.
16. Ledergerber B, Furrer H, Rickenbach M, et al. Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study. Clin Infect Dis. 2007;45:111-9.
17. Wand H, Calmy A, Carey DL, et al. Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection. AIDS. 2007;21:2445-53.
18. Sofi F, Abbate R, Gensini GF, Casini A. Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. Am J Clin Nutr. 2010;92:1189-96.
19. The InterAct Consortium. Mediterranean diet and type 2 diabetes risk in the European prospective investigation into cancer and nutrition (EPIC) study. Diabetes Care 2011;34:1913-1918.
20. Lumpkin MM. US Food Drug Administration public health advisory: reports of diabetes and hyperglycemia in patients receiving protease inhibitors for the treatment of human immunodeficiency virus (HIV). Rockville, MD: US Food and Drug Administration; 1997.
21. Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA. Diagnosis, prediction and natural course of HIV-1: protease inhibitor-associated lipodystrophy, hyperlipidaemia and adiabetes mellitus: a cohort study. Lancet. 1999;353:2093-9.
22. Justman JE, Benning L, Danoff A, et al. Protease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIVinfected women. J Acquir Immune Defic Syndr. 2003;32:298- 302.
23. Brambilla AM, Novati R, Calori G, et al. Stavudine- or indinavircontaining regimens are associated with an increate risk of diabetes mellitus in HIV-infected individuals. AIDS. 2003;17: 1993-5.
24. Brown TT, Li X, Cole SR, et al. Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the Multicenter AIDS Cohort Study. AIDS. 2005;19:1375-83.
25. Garcia-Benayas T, Rendon AL, Rodriguez-Novoa S, et al. Higher risk of hyperglycemia in HIV-infected patients treated with didanosine plus tenofovir. AIDS Res Hum Retroviruses. 2006;22: 333-7.
26. Modest GA, Fuller J. Abacavir and diabetes. N Engl J Med. 2001; 344:142-4.
27. Gnavi R, Karaghiosoff L, Costa G, Merletti F, Bruno G. Socioeconomic differences in the prevalence of diabetes in Italy: the population based Turin study. Nutr Metab Cardiovasc Dis. 2008; 18:678-82.